Joint Department, The 2nd Ward of Joint Surgery, Tianjin Hospital, 406 Jiefangnan Rd, Tianjin, 300211, People's Republic of China.
Joint Department, The 1st Ward of Joint Surgery, Tianjin Hospital, Tianjin, China.
Clin Rheumatol. 2019 Aug;38(8):2119-2127. doi: 10.1007/s10067-019-04510-8. Epub 2019 Apr 10.
To develop and validate the Chinese version of the Joint Protection Self-Efficacy Scale (CJP-SES) in patients with rheumatoid arthritis (RA) in China.
(1) Translation of the original German/English version JP-SES and cultural adaptation into the Chinese language; (2)Validation of the CJP-SES with the Chinese versions of the Arthritis Self-Efficacy Scale-8 (ASES-8), the Laffrey Health Conception Scale (LHCS), 10-item Perceived Efficacy in Patient-Physician Interactions Scale (PEPPI-10), Disease Activity Score-28 (DAS-28) and Health Assessment Questionnaire (HAQ). Instrument measurement included reliability testing, item generation, construct validity, test-retest reliability, and correlation with other measurements. Confirmatory factor analysis was applied to determine construct validity and internal consistency. One hundred fifteen patients with RA were investigated.
Finally, 105 RA patients were included in the analysis. Confirmatory factor analysis demonstrated fit for a unidimensional model of the JP-SES. Additionally, the scale showed internal consistency (Cronbach's α coefficient 0.922), kappa coefficient (0.653), and test-retest reliability (ICC = 0.94). Weak correlations with other scores for the other instruments, such as the Chinese version of ASES-8 (0.263) and PEPPI-10 (0.326). Correlation with duration (0.274), moderate correlation with BMI (- 0.438) and DAS-28 (- 0.493), and strong correlation with HAQ (- 0.644) were found in this research.
This is the first study to adapt and validate the JP-SES into Chinese for use in patients with RA. Our research showing that the CJP-SES has a good construct validity, internal consistency, and test-retest reliability. This scale can help doctors and nurses to assess the self-efficacy of patients with RA.
ClinicalTrials.gov Identifier: TJYY-YLS-036.
在中国类风湿关节炎（RA）患者中开发和验证联合保护自我效能量表（CJP-SES）的中文版。
（1）将原始德文/英文版本的 JP-SES 翻译成中文并进行文化适应；（2）使用关节炎自我效能量表-8（ASES-8）、Laffrey 健康观念量表（LHCS）、10 项医患互动感知效能量表（PEPPI-10）、疾病活动评分-28（DAS-28）和健康评估问卷（HAQ）对 CJP-SES 进行验证。仪器测量包括可靠性测试、项目生成、结构有效性、测试-重测信度以及与其他测量的相关性。验证性因子分析用于确定结构有效性和内部一致性。对 115 例 RA 患者进行调查。
最终，105 例 RA 患者纳入分析。验证性因子分析表明 JP-SES 的单维模型拟合良好。此外，该量表还具有内部一致性（Cronbach's α 系数为 0.922）、kappa 系数（0.653）和测试-重测信度（ICC=0.94）。与其他仪器的其他评分的相关性较弱，例如中文版 ASES-8（0.263）和 PEPPI-10（0.326）。与持续时间（0.274）呈弱相关，与 BMI（-0.438）和 DAS-28（-0.493）呈中度相关，与 HAQ（-0.644）呈强相关。
这是首次将 JP-SES 改编并验证为中文用于 RA 患者的研究。我们的研究表明，CJP-SES 具有良好的结构有效性、内部一致性和测试-重测信度。该量表有助于医生和护士评估 RA 患者的自我效能。
ClinicalTrials.gov 标识符：TJYY-YLS-036。
